Secondary HIV transmission rates in a mixed-gender sample

International Journal of STD and AIDS

Volumn 11, Issue 1, 2000, Pages 38-44

  Pinkerton, Steven D ^a   Abramson, Paul R ^b   Kalichman, Seth C ^a,c   Catz, Sheryl L ^a   Johnson Masotti, Ana P ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

HIV transmission; Human immunodeficiency virus; Modelling; Risk behaviour

Indexed keywords

ADULT; ARTICLE; BISEXUALITY; CONTROLLED STUDY; FEMALE; HEALTH EDUCATION; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL; RISK; SELF REPORT; SEX DIFFERENCE; SEXUAL BEHAVIOR; UNITED STATES; VIRUS TRANSMISSION;

DANGEROUS BEHAVIOR; FEMALE; GEORGIA; HIV INFECTIONS; HUMANS; MALE; MODELS, THEORETICAL; PREVALENCE; SEXUAL BEHAVIOR;

EID: 0033978983     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462001914887     Document Type: Article

References (46)

1. Cleary PD, van Devanter N, Rogers T, et al. Behavior changes after notification of HIV infection. Am J Public Health 1991;81:1586-90
2. Higgins DL, Galavotti C, O'Reilly KR, et al. Evidence for the effects of HIV antibody counseling and testing on risk behavior. JAMA 1991;266:2419-29
3. Kilmarx PH, Hamers FF, Peterman TA. Living with HIV: experiences and perspectives of HIV-infected sexually transmitted disease clinic patients after posttest counseling. Sex Transm Dis 1998;25:28-37
4. Lemp GF, Hirozawa AM, Givertz D, et al. Seroprevalence of HIV and risk behaviors among young homosexual and bisexual men. JAMA 1994;272:449-54
5. Posner SF, Marks G. Prevalence of high-risk sex among HIV-positive gay and bisexual men: a longitudinal analysis. Am J Prevent Med 1996;12:472-7
6. Robins AG, Dew MA, Davidson S, Penkower L, Becker JT, Kingsley L. Psychosocial factors associated with risky sexual behavior among HIV-seropositive gay men. AIDS Educ Prev 1994;6:483-92
7. Wiktor SZ, Biggar RJ, Melbye M, et al. Effect of knowledge of human immunodeficiency virus infection on sexual activity among homosexual men. J Acquir Immune Defic Syndr 1990;3:62-8
8. Kalichman SC, Continued sexual risk behavior among HIV-seropositive, drug-using men - 1993. MMWR 1996; 45:151
9. Rhodes TJ, Donoghoe MC, Hunter G, Stimson G. Continued risk behavior among HIV positive drug injectors in London: implications for intervention. Addiction 1993;88: 1553-60
10. Singh BK, Koman JJ, Catan V, Souply K, Birkel R, Golaszewski T. Sexual risk behavior among injection drug-using human immunodeficiency virus positive clients. Int J Addict 1993;28:735-47
11. Kline A, van Landingham M. HIV-infected women and sexual risk reduction: the relevance of existing models of behavior change. AIDS Educ Prev 1994;6:390-402
12. Wenger NS, Kusseling FS, Beck K, Shapiro MF. Sexual behavior of individuals infected with the human immunodeficiency virus. Arch Intern Med 1994;154;1849-54
13. Wilson TE, Massad LS, Riester KA, et al. Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: results from the Women's Interagency HIV Study. AIDS 1999;13:591-8
14. King-Spooner S. HIV prevention and the positive populations. Int J STD AIDS 1999;10:141-50
15. Marks G, Burris S, Peterman TA. Reducing sexual transmission of HIV from those who know they are infected: the need for personal and collective responsibility. AIDS 1999;13:297-306
16. Weinhardt LS, Carey MP, Johnson BT, Bickham NL. Effects of HIV counseling and testing on sexual risk behavior: meta-analytic review of published research, 1985-1997. Am J Public Health 1999;89:1397-405
17. Pinkerton SD, Abramson PR. An alternative model of the reproductive rate of HIV infection: formulation, evaluation, and implications for risk reduction interventions. Evaluation Rev 1994;18:371-88
18. Kalichman SC. Psychological and social factors correlates of high-risk sexual behavior among men and women living with HIV-AIDS. AIDS Care (in press)
19. Pinkerton SD, Abramson PR. The Bernoulli-process model of HIV transmission: applications and implications. In: Holtgrave DR, ed. Handbook of Economic Evaluation of HIV Prevention Programs. New York: Plenum Press, 1998
20. Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med 1997;44:1303-12
21. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health 1996;86:642-54
22. Pinkerton SD, Abramson PR. Evaluating the risks: a Bernoulli process model of HIV infection and risk reduction. Evaluation Rev 1993;17:504-28
23. Bachetti P. Estimating the incubation period of AIDS by comparing population infections and diagnosis patterns. J Am Statist Ass 1990;412:1002-8
24. Lui K-J, Darrow WW, Rutherford GW. A model based estimate of the mean incubation period for AIDS in homosexual men. Science 1988;240:1333-5
25. Taylor JJG, Munoz A, Bass SM, et al. Estimating the distribution of times from HIV seroconversion to AIDS using multiple imputation. J Acquir Immune Defic Syndr 1990;4:69-75
26. Cameron W, Heath-Chiozzi M, Kravcik S. Prolongation of life and prevention of AIDS in advanced HIV immunodeficiency with ritonavir [abstract LB6a]. Third Conference on Retroviruses and Opportunistic Infections. Washington DC, January 1996
27. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society - USA panel. JAMA 1998;280:78-86
28. Deeks SG, Smith M, Holodniy M, Kahn JO. HIV-1 protease inhibitors: a review for clinicians. JAMA 1997;276:146-54
29. Laezari J, Haubrich R, Burger HV. Improved survival and decreased progression of HIV in patients treated with saquinavir (invirase SQV) plus HIVID (zalcitabine, ddc) [abstract LBB6033]. XI International Conference on AIDS. Vancouver, July 1996
30. Porter K. Survival following HIV seroconversion: evidence of a recent change? [abstract 13335]. 12th World AIDS Conference, Geneva, June-July 1998
31. Chancellor JV, Hill AM, Sabin CA, Simpson KN, Youle M. Modeling the cost-effectiveness of lamivudine/zidovudine combination therapy in HIV infection. Pharmacoeconomics 1997;12:54-66
32. Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. J Acquir Immune Defic Syndr 1997;16:54-62
33. Moore RD, Bartlett JG. Combination antiretroviral therapy in HIV infection: an economic perspective. Pharmacoeconomics 1996;10:109-13
34. Garnett GP. The basic reproductive rate of infection and the course of HIV epidemics. AIDS Patient Care STDs 1998;12: 435-49
35. Garnett GP, Johnson AM. Coining a new term in epidemiology: concurrency and HIV. AIDS 1997;11:641-8
36. Morris M, Kretzschmar M. Concurrent partnerships and transmission dynamics in networks. Social Networks 1995;17:299-318
37. Morris M, Kretzschmar M. Concurrent partnerships and the spread of HIV. AIDS 1997;11:681-3
38. Musicco M, Lazzarin A, Nicolosi A, et al. Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Arch Intern Med 1994;154:1971-6
39. Ragni MV, Faruki H, Kingsley LA. Heterosexual HIV-1 transmission and viral load in hemophilic patients. J Acquir Immune Defic Syndr 1998;17:42-5
40. Vernazzi PL, Gilliam BL, Dyer J, et al. Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS 1997;11:987-93
41. Pinkerton SD, Holtgrave DR. Combination antiretroviral therapies for HIV: some economic considerations. In: Ostrow DG, Kalichman SC eds. Psychosocial and Public Health Impacts on New HIV Therapies. New York: Kluwer Academic/Plenum, 1999
42. Anderson RM, Gupta S, May RM. Potential of community-wide chemotherapy or immunotherapy to control the spread of AIDS. Nature 1991;350:356-9
43. Des Jarlais DC, Padian NS, Winkelstein W Jr. Targeted HIV-prevention programs. N Engl J Med 1994;331:1451-3
44. Kahn JG. The cost-effectiveness of HIV prevention targeting: how much more bang for the buck? Am J Public Health 1996;86:1709-12
45. Katz MH, Gerberding JL. Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use. N Engl J Med 1997;336:1098-100
46. Mastro TD, de Vincenzi I. Probabilities of sexual HIV-1 transmission. AIDS 1996;10(suppl. A):S75-S82